Koert Ritmeijer

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis et al. · New England Journal of Medicine · 2022 · 352 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Reviews Of Anti‐infective Agents: Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis

Caryn Bern, Jill Adler‐Moore, Juan Berenguer et al. · Clinical Infectious Diseases · 2006 · 340 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

A Comparison of Miltefosine and Sodium Stibogluconate for Treatment of Visceral Leishmaniasis in an Ethiopian Population with High Prevalence of HIV Infection

Koert Ritmeijer, Abren Dejenie, Yibeltal Assefa et al. · Clinical Infectious Diseases · 2006 · 220 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Conflict and Kala‐Azar: Determinants of Adverse Outcomes of Kala‐Azar among Patients in Southern Sudan

Simon M. Collin, Robert N. Davidson, Koert Ritmeijer et al. · Clinical Infectious Diseases · 2004 · 180 citations

Agriculture, Infectious Diseases, Pharmacotherapy +14

Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome

Koert Ritmeijer, H Veeken, Yosef Melaku et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 2001 · 122 citations

Pharmacy, Infectious Diseases, Pharmacology +17